Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DaVita (DVA)
NYSE:DVA
Holding DVA?
Track your performance easily
DVA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$103.40 - $169.52
Previous Close$166.17
Volume523.46K
Average Volume (3M)811.45K
Market Cap
$13.63B
Enterprise Value$26.57B
Total Cash (Recent Filing)$1.09B
Total Debt (Recent Filing)$12.20B
Price to Earnings (P/E)17.9
Beta0.77
Next Earnings
Feb 18, 2025EPS Estimate
$2.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.28
Shares Outstanding82,000,000
10 Day Avg. Volume868,499
30 Day Avg. Volume811,451
Standard Deviation0.10
R-Squared0.22
Alpha0.00853
Financial Highlights & Ratios
Price to Book (P/B)34.20
Price to Sales (P/S)1.02
Price to Cash Flow (P/CF)4.00
P/FCF Ratio4.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.10
Enterprise Value/Gross Profit6.95
Enterprise Value/Ebitda103.24
Forecast
1Y Price Target
$157.25Price Target Upside-4.12% Downside
Rating ConsensusHold
Number of Analyst Covering4
DaVita News
PremiumCompany Announcements
DaVita Inc. Reports Strong Q3 2024 Performance
Bulls Say, Bears Say
Bulls Say
Financial GuidanceFull-year 2024 guidance was left unchanged despite the Baxter IV shortage headwind.
Growth ExpectationsDVA still expects full-year 2024 treatment growth to be between 0.5% and 1.0%.
Operational EfficiencyClinic closure normalizing will be a tailwind.
Bears Say
Mortality ImpactDVA expects mortality to remain a headwind to volumes next year.
Regulatory ImpactDVA is unable to quantify the potential financial impact of the inclusion of oral-only phosphate binders into the Medicare payment bundle.
Volume GrowthDVA experienced pressure on treatment volumes in the quarter from hurricanes.
---
Ownership Overview
1.85% Insiders
10.44% Mutual Funds
54.43% Other Institutional Investors
17.30% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DVA FAQ
What was DaVita’s price range in the past 12 months?
DaVita lowest stock price was $103.40 and its highest was $169.51 in the past 12 months.
What is DaVita’s market cap?
Currently, no data Available
When is DaVita’s upcoming earnings report date?
DaVita’s upcoming earnings report date is Feb 18, 2025 which is in 76 days.
How were DaVita’s earnings last quarter?
DaVita released its earnings results on Oct 29, 2024. The company reported $2.59 earnings per share for the quarter, missing the consensus estimate of $2.724 by -$0.134.
Is DaVita overvalued?
According to Wall Street analysts DaVita’s price is currently Overvalued.
Does DaVita pay dividends?
DaVita does not currently pay dividends.
What is DaVita’s EPS estimate?
DaVita’s EPS estimate is $2.14.
How many shares outstanding does DaVita have?
DaVita has 82,000,000 shares outstanding.
What happened to DaVita’s price movement after its last earnings report?
DaVita reported an EPS of $2.59 in its last earnings report, missing expectations of $2.724. Following the earnings report the stock price went down -10.795%.
Which hedge fund is a major shareholder of DaVita?
Among the largest hedge funds holding DaVita’s share is Berkshire Hathaway Inc. It holds DaVita’s shares valued at 6B.
---
DaVita Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$157.25 (-4.12% Downside)
$157.25 (-4.12% Downside)
Blogger Sentiment
Bullish
DVA Sentiment 91%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 118.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $9.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days <0.1%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
56.97%
12-Months-Change
Fundamentals
Return on Equity
104.38%
Trailing 12-Months
Asset Growth
3.40%
Trailing 12-Months
Company Description
DaVita
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
---
DVA Earnings Call
Q3 2024
0:00 / 0:00
---
DVA Revenue Breakdown
95.34% U.S. dialysis
4.66% Ancillary services
---
DVA Stock 12 Month Forecast
Average Price Target
$157.25
▼(-4.12% Downside)
Technical Analysis
Best Analysts Covering DVA
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-15.90%
assigned a sell rating last month
Copying Joanna Gajuk's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -15.90% per trade.
---